MUEs conducted on frequently prescribed, expensive drug therapy help to identify misuse of medications. Protocols that empower pharmacists to accurately assess treatment can improve patient care while minimizing direct drug costs.

Continue reading " Uncomplicated Gastroesophageal Reflux Disease: DISCUSSION "

Forty-seven patients who met inclusion and exclusion criteria participated in the project. Thirteen patients either did not have a telephone or were not willing to take part in the project. The remaining 34 patients were contacted by telephone and were subsequently stepped down to lansoprazole canadian administered once a day.

Continue reading " Uncomplicated Gastroesophageal Reflux Disease: RESULTS "

Patients This project reviewed Kansas City VA Medical Center patients identified as part of an MUE. In order to obtain an adequate group, all patients receiving a one-month supply of the formulary PPI, lansoprazole canadian, and with a quantity of 60 doses or greater from January 1 to December 31, 1999, were evaluated. Criteria for [...]

Continue reading " Uncomplicated Gastroesophageal Reflux Disease: METHODS "

INTRODUCTION The Medical Advisory Panel for the Veterans Health Administration Pharmacy Benefits Management Strategic Healthcare Group (PBM SHG) coordinates the development of guidelines for the pharmacological management of common disease states treated within the Veterans Affairs (VA) system. These documents are based on nationally recognized treatment guidelines and current literature with the purpose of assisting [...]

Continue reading " Uncomplicated Gastroesophageal Reflux Disease "